BridgeMD
Compares treatment options for Supraventricular Tachycardia (SVtach)
Official title Efficacy of Adenosine as Compared to Verapamil in Paroxysmal Supraventricular Tachycardia (pSVT) Patients
ClinicalTrials.gov ID: NCT06717685
What this study is testing
What is Adenosine?
Adenosine is an investigational medicine, given as an once-daily, being studied as a potential treatment for supraventricular tachycardia (svtach).
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Supraventricular tachycardia (SVT) is a term widely used to describe tachycardial dysrhythmias, paroxysmal SVT (PSVT) is a narrow term including only AV nodal re-entrant tachycardia (AVNRT) and atrioventricular re-entrant tachycardia (AVRT), both of which can cause discomfort and, in some cases, life-threatening symptoms. Usually Carotid sinus massage is done to lower the pulse rate and after the standard time specific verapamil dose is administered.
- Phase 3: a large, late-stage study
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 70
You may be able to join if
- Stable SVT (not requiring cardioversion, fully conscious, maintaining systolic blood pressure of \>90mmHg)
- Alert enough and able to give consent
- Able to lie flat and non-painful legs during passive leg raising
You likely can't join if
- Unstable SVT (Semiconscious, drowsy, breathless, systolic BP \<90mmHg)
- Not able to give consent
- Orthopnea causing inability to lie flat
- Atrial fibrillation/atrial flutter
- Recent MI (within last 7 days)
- Ongoing ischemia as indicated by chest pain or ST segment depression/elevation in ECG
See the full eligibility criteria
- Stable SVT (not requiring cardioversion, fully conscious, maintaining systolic blood pressure of \>90mmHg)
- Alert enough and able to give consent
- Able to lie flat and non-painful legs during passive leg raising
- Unstable SVT (Semiconscious, drowsy, breathless, systolic BP \<90mmHg)
- Not able to give consent
- Orthopnea causing inability to lie flat
- Atrial fibrillation/atrial flutter
- Recent MI (within last 7 days)
- Ongoing ischemia as indicated by chest pain or ST segment depression/elevation in ECG
- Aortic stenosis
- All trimesters of pregnancy
The study team makes the final eligibility decision.
Where it's taking place
- Lahore, Punjab Province, Pakistan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 70 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Lahore, Punjab Province, Pakistan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.